Advances clinical research with wearable sensor solutions. Provides validated wearable data analytics for clinical trials,enabling continuous patient monitoring and novel digital biomarker development. Raised $27M.
Vendor description
Wearable sensor analytics platform for clinical trials and digital biomarker development
Wearable sensor data analytics,Digital biomarker development,Continuous patient monitoring,DCT-enabling technology
- Validated wearable analytics
- Digital biomarker expertise
- FDA-aligned methodology
- Continuous monitoring capability
- Niche wearable focus
- Smaller company
- Requires sensor hardware integration
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Pricing
$
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | SaaS + Services |
| Customer segment | Mid-market |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Small to Large |
| Therapeutic areas | CNS, Cardiology, Rare Diseases, Metabolic Diseases |
Related vendors
Editorial ranking
See how VivoSense compares - best Home health / DCT (decentralized trials) vendors for clinical trials.




